SAM
ANIK icon

Smartleaf Asset Management’s Anika Therapeutics ANIK Stock Holding History

Smartleaf Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Hold
1,261
– – ﹤0.01% 2039
2026
Q1 		$17.8K Buy
1,261
+610
+94% +$7.08K ﹤0.01% 2023
2025
Q4 		$6.22K Buy
651
+540
+486% +$5.17K ﹤0.01% 2613
2025
Q3 		$1.01K Buy
111
+67
+152% +$640 ﹤0.01% 2745
2025
Q2 		$472 Buy
+44
New +$555 ﹤0.01% 2598
2025
Q1 		– Sell
-21
Closed -$341 – 2867
2024
Q4 		$341 Sell
21
-150
-88% -$2.96K ﹤0.01% 2827
2024
Q3 		$4.2K Buy
171
+72
+73% +$1.87K ﹤0.01% 2197
2024
Q2 		$2.55K Buy
+99
New +$2.57K ﹤0.01% 2130

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Smartleaf Asset Management's ANIK Position: Q2 2026 in Review

Smartleaf Asset Management held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 1,261 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

Smartleaf Asset Management first reported a position in ANIK in Q2 2024 and has held it in 8 quarters since. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Smartleaf Asset Management held 1,261 shares of Anika Therapeutics worth $18.9K as of Q2 2026.
  • Smartleaf Asset Management left its Anika Therapeutics share count unchanged in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2039 holding.
  • Smartleaf Asset Management first reported a position in Anika Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.